Consolidated Figures in USD Millions.
| Metric | 2022 | 2023 | 2024 | 2025 |
|---|
| Total Revenue | 1,199.12 | 1,333.47 | 1,473.86 | 2,023.99 |
| Cost Of Revenue | 1,050.84 | 1,135.68 | 1,069.21 | 1,436.59 |
| Gross Profit | 148.29 | 197.79 | 404.65 | 587.40 |
| Operating Expense | 409.28 | 406.70 | 381.74 | 514.60 |
| Operating Income | -260.99 | -208.91 | 22.91 | 72.80 |
| EBITDA | -198.89 | -135.13 | 89.33 | 20.05 |
| EBIT | -260.50 | -197.74 | 36.28 | -30.52 |
| Pretax Income | -313.99 | -306.04 | -26.36 | -84.40 |
| Tax Provision | 1.10 | 1.89 | 0.85 | 2.74 |
| Net Income | -301.41 | -302.12 | -29.23 | -88.43 |
| Net Income Common Stockholders | -301.41 | -302.12 | -29.23 | -88.43 |
| Total Expenses | 1,460.12 | 1,542.38 | 1,450.95 | 1,951.19 |
| Interest Expense | 53.49 | 108.30 | 62.64 | 53.89 |
| Interest Income | 3.89 | 19.89 | 25.34 | 34.07 |
| Research And Development | 150.61 | 155.87 | 148.63 | 185.99 |
| Selling General And Administration | 258.67 | 250.84 | 233.11 | 328.61 |
| Normalized EBITDA | -190.50 | -129.21 | 117.20 | 119.17 |
| Normalized Income | -294.78 | -297.43 | -7.20 | -10.13 |
| Basic EPS | -1.62 | -1.42 | -0.13 | -0.37 |
| Diluted EPS | -1.62 | -1.42 | -0.13 | -0.37 |
| Tax Effect Of Unusual Items | -1.76 | -1.25 | -5.85 | -20.81 |
| Tax Rate For Calcs | 0.21 | 0.21 | 0.21 | 0.21 |
| Total Unusual Items | -8.39 | -5.93 | -27.88 | -99.12 |
| Total Unusual Items Excluding Goodwill | -8.39 | -5.93 | -27.88 | -99.12 |
| Net Income From Continuing Operation Net Minority Interest | -301.41 | -302.12 | -29.23 | -88.43 |
| Reconciled Depreciation | 61.61 | 62.61 | 53.05 | 50.57 |
| Reconciled Cost Of Revenue | 1,050.84 | 1,135.68 | 1,069.21 | 1,436.59 |
| Net Interest Income | -49.61 | -88.41 | -37.29 | -19.82 |
| Net Income From Continuing And Discontinued Operation | -301.41 | -302.12 | -29.23 | -88.43 |
| Total Operating Income As Reported | -260.99 | -208.91 | 22.91 | 72.80 |
| Diluted Average Shares | 185.91 | 212.68 | 227.37 | 240.40 |
| Basic Average Shares | 185.91 | 212.68 | 227.37 | 240.40 |
| Diluted NI Availto Com Stockholders | -301.41 | -302.12 | -29.23 | -88.43 |
| Otherunder Preferred Stock Dividend | 0 | 0 | 0 | 0 |
| Minority Interests | 13.68 | 5.82 | -2.02 | -1.29 |
| Net Income Including Noncontrolling Interests | -315.09 | -307.94 | -27.20 | -87.14 |
| Net Income Continuous Operations | -315.09 | -307.94 | -27.20 | -87.14 |
| Other Income Expense | -3.39 | -8.72 | -11.97 | -137.39 |
| Other Non Operating Income Expenses | 5 | -2.79 | 15.90 | 2.15 |
| Special Income Charges | -8.96 | -4.29 | -27.18 | -98.58 |
| Other Special Charges | 8.96 | 4.29 | 27.18 | 98.58 |
| Earnings From Equity Interest | 0 | 0 | 0 | -40.42 |
| Gain On Sale Of Security | 0.57 | -1.64 | -0.69 | -0.54 |
| Net Non Operating Interest Income Expense | -49.61 | -88.41 | -37.29 | -19.82 |
| Interest Expense Non Operating | 53.49 | 108.30 | 62.64 | 53.89 |
| Interest Income Non Operating | 3.89 | 19.89 | 25.34 | 34.07 |
| Selling And Marketing Expense | 90.93 | 89.96 | 68 | 130.23 |
| General And Administrative Expense | 167.74 | 160.88 | 165.10 | 198.38 |
| Other Gand A | 167.74 | 160.88 | 165.10 | 198.38 |
| Operating Revenue | 1,199.12 | 1,333.47 | 1,473.86 | 2,023.99 |
